INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023
-
Revenues Increased 10% in the Twelve Months Ended
December 31, 2023 versus prior year -
Revenue of
$12.3 million in the Twelve Months EndedDecember 31, 2023 was the highest in Company history -
Gross Profit Increased
$1.1 million , or 17%, in the Twelve Months EndedDecember 31, 2023 versus prior year -
Approximately
$0.6 million ofNet Cash provided by operating activities in the Twelve Months EndedDecember 31, 2023 , an increase of over$2.0 million versus prior year.
Revenue for the twelve months ended
The Company reported a net loss for the twelve months ended
As of
The following provides a summary of our current business segment performance for the twelve-month periods ended
Theranostics Products (formerly Radiochemical Products)
Revenue from the Theranostics Products segment increased approximately 13% for the twelve-month period ended
Nuclear Medicine Products
Revenue from Nuclear Medicine Products, operating as
Cobalt Products
Revenue from the sale of cobalt products for the twelve-month period decreased approximately 10% compared to the same period in 2022. The decrease in revenue over the twelve-month period was largely due to planned waste disposal activities which halted production for a large part of the fourth quarter of 2023. The Company remains the only domestic manufacturer and supplier of high activity cobalt-60 sealed-source products.
Medical Device Products
The Company purchased medical devices and related assets and intellectual property rights from
|
|
||||||||||||
Twelve months ended - |
|
|
|||||||||||
|
|
2023 |
|
2022 |
|
$ |
|
% |
|
|
|||
Sale of product |
|
$ |
12,267,385 |
|
$ |
11,181,988 |
|
$ |
1,085,397 |
|
10 % |
|
|
Gross profit |
|
$ |
7,378,976 |
|
$ |
6,290,061 |
|
$ |
1,088,915 |
|
17 % |
|
|
Total Operating Expense |
|
$ |
8,155,275 |
|
$ |
7,492,958 |
|
$ |
662,317 |
|
9 % |
|
|
Operating Loss Before Other Exp |
|
$ |
(776,299) |
|
$ |
(1,202,897) |
|
$ |
426,598 |
|
-35 % |
|
|
Other Income (Expense) |
|
$ |
(92,717) |
|
$ |
1,506,135 |
|
$ |
(1,598,852) |
|
106 % |
|
|
Net Income (Loss) |
|
$ |
(869,016) |
|
$ |
303,238 |
|
$ |
(1,172,254) |
|
-387 % |
|
|
Net income per common share – basic: |
|
|
|
|
|
|
|
|
- |
|
- |
||
Net income per common share – diluted: |
|
|
|
|
|
|
|
|
- |
|
- |
||
Weighted avg. shares outstanding - basic |
|
|
517,777,847 |
|
|
510,794,145 |
|
|
|
|
|
||
Weighted avg. shares outstanding - diluted |
|
|
517,777,847 |
|
|
510,794,145 |
|
|
|
|
|
About
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the Company's future growth expectations. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance, or achievements of
FOR MORE INFORMATION, CONTACT:
Investor and Public Relations
david@creativeoptionscommunications.com
www.creativeoptionsmarketing.com
Phone: 972-814-5723
View original content:https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-fiscal-results-for-fiscal-year-2023-302104073.html
SOURCE